Michael Bourn was undoubtedly a stronger player than B.J. Upton in 2012, yet something surprising happened when free agency opened earlier this month; Bourn’s most recent team, the Braves, and his original team, the Phillies, both made Upton the priority in talks.
Did it have to do with the price tag? Bourn was seeking more money, but the figures were so astronomical with both that it hardly seemed likely to make all of the difference. Upton just got $15.05 million per year for five years from the Braves. Bourn was asking for a sixth year, but he never figured to do much better than the $75 million that Upton got.
It’s all really curious to me. I see Upton as the significantly better bet going forward, but I wasn’t really expecting the Braves or especially the Phillies to view it the same way. Upton is two years younger, which makes a real difference. Bourn, though, is the better fielder and the better leadoff candidate. Upton also has a reputation for not always hustling. No one seems to view him as a bad guy overall, but his head doesn’t always seem to be in the game. Bourn has no such reputation.
Anyway, most suspect the Phillies will now turn to Bourn. And maybe they will. Still, I don’t think they would have been all over Upton like they were if they were eager to pay Bourn’s price. They might mix in a changeup and target the less pricey Angel Pagan instead. They also haven’t ruled out bringing back Shane Victorino, though Victorino needs to get a whole lot more realistic about his salary demands first.
Bourn will still get his big payday, but now I suspect he may have to settle for a bit less than Upton got, whether it’s four years and $60 million or five years and $70 million.
The Cleveland Indians just announced that they’ve acquired catcher Chris Gimenez from the Texas Rangers in exchange for cash considerations.
Gimenez knows his way to Progressive Field. Indeed, this will be his third stint with the Indians organization. He was their 19th round pick in the 2004 draft, made his big league debut with the club in 2009 and stayed through the 2010 season. He came back in 2014 for eight games, now he’s back again. He has yet to play in 2016 due to a ankle issue. He as doing minor league rehab before being DFA’d by the Rangers yesterday.
Come back to Cleveland, Chris. You always will have a home in Cleveland.
Last year the Dodgers suspended infielder Erisbel Arruebarrena for the remainder of the season“for repeated failures to comply with his contract.” Arreubarrena appealed his suspension to Major League Baseball and it was reduced to thirty days, though that was said to be a settlement between Arruebarrena and the Dodgers as opposed to a full adjudication.
Here we go again: Gabe Kapler, the Dodgers Director of Player Development, just announced that the Dodgers have suspended Arruebarrena for the rest of 2016 “for repeated failure to comply with the terms of his contract.” No further specifics were given.
Arruebarrena was signed out of Cuba to to a five-year, $25 million deal back in 2013. He played in 22 games in the bigs in 2014, hitting .195. He was dropped from the 40-man roster after that season, however, and after his suspension last year managed to only play in 53 games across three levels. He hit better, but none of his action was above Double-A and he was 25 at the time. He’s played 17 games at Double-A this year and isn’t hitting.
What he was or was not doing with respect to his contract is unclear at the moment, but this isn’t exactly the kind of thing that happens on a daily basis, especially with dudes under contract for $25 million, so we’ll probably hear more eventually.
NEW YORK (AP) Braves right fielder Nick Markakis has left the team because of a family emergency.
Manager Fredi Gonzalez said before Wednesday’s game against the Mets that Markakis had headed home to Maryland. The veteran is expected to be back in time for Friday’s home game against Arizona. Atlanta is off Thursday.
Chase d’Arnaud is starting in right field and Mallex Smith is leading off Wednesday.
Markakis is hitting .281 with no home runs and 20 RBIs.
T.J. Quinn of ESPN’s Outside the Lines reports that another major leaguer — or possibly several of them — will soon be suspended for PEDs. He says that, as was the case with Chris Colabello and others recently, the drug will be Turinabol, which is an old school anabolic steroid. Quinn says that improved testing procedures, which he details in the article, are a likely reason for the spike in Turinabol positives, though it’s also possible that there is a tainted supplement being taken, though he deems that speculative.
What isn’t mentioned is . . . how an ESPN reporter knows a positive test is coming when the drug testing program is supposed to be confidential. Someone with the league or the union must be telling him, right? That’s sort of messed up, no? Will MLB investigate who is leaking such things?
Whatever the case, we’ll soon have a new police blotter item, it seems.